US Congress to intensify probe on prices against Indian pharma firms – Business Standard News
0
The probe initiated by the US legislature against Sun Pharma and Dr Reddy’s over the steep increase of their drug prices in the US market is set to intensify. A panel formed by the Congress will hold its first hearing on November 20.
Read more – Business Standard News